KATOR Patent Portfolio Increased to 7 Issued U.S. Patents

LOGAN, Utah, March 5, 2019 /PRNewswire/ — KATOR, an early stage medical device company focused on advanced tissue-to-bone repair systems, announced today that the United States Patent and Trademark Office (“USPTO”) has recently granted the company additional patents related to its innovative suture anchor technology.

In the last 3 months, the USPTO has granted 4 additional US Patents that cover the KATOR technology. This expands the total patent portfolio to 7 issued US patents with additional patents pending. The 4 newly issued patents are: US Patent 10,143,462 entitled “Transosseous Suture Anchor Method,” US Patent 10,154,868 entitled “Transosseous Method,” US Patent 10,194,898 entitled “Suture Anchor,” and US Patent 10,226,243 entitled “Transosseous Suture Anchor.”

The KATOR technology features the KATOR® Knotless Suture Anchor and the BoneStitch™ Transosseous Suture Passer, and both products facilitate arthroscopic procedures. The KATOR® Knotless Suture Anchor locks more strands of suture than any equivalent size knotless suture anchor on the market. Additionally, the KATOR® Knotless Suture Anchor facilitates suture tension adjustment after the suture anchor is fully seated in the bone, allowing the surgeon to evaluate the final repair construct and make necessary adjustments prior to the knotless locking of the suture. The BoneStitch™ Transosseous Suture Passer enables the fastest and most reliable technique on the market for simultaneously creating a bone tunnel and passing suture through the bone tunnel.

In a recent publication in a leading peer review medical journal, biomechanical testing demonstrated the superior performance of a knotless, transosseous repair using only 2 KATOR® Knotless Suture Anchors compared to a traditional knotless, transosseous equivalent repair using 4 suture anchors.1

KATOR is a medical device company founded and operated by Surgical Frontiers.

About Surgical Frontiers
Surgical Frontiers develops advanced surgical technologies that are ready for clinical use. Focused primarily on musculoskeletal injuries and pathologies, the company collaborates with surgeons, industry, universities, and investors to bring advanced surgical technologies to the market that improve healthcare.

Mr. Wade Fallin 
Chief Executive Officer

1. Tashjian, RZ, et al., “Biomechanical Comparison of Transosseous Knotless Rotator Cuff Repair Versus Transosseous Equivalent Repair: Half The Anchors With Equivalent Biomechanics?” Arthroscopy, 2018 Jan;34(1):58-63.

SOURCE Surgical Frontiers

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button